Objective
The purpose of this study was to compare costs for end-oflife
care in NSCLC patients in Ontario, Canada, and in
Surveillance, Epidemiology and End Results (SEER)
areas, representing 14% of the United States.
This study will advance methods for international comparisons using
administrative data to study the costs of end-of-life care in cancer.